ACETO Subsidiary Acquires Three ANDAs From Endo - Quick Facts

(RTTNews) - ACETO Corporation (ACET) announced that Rising Pharmaceuticals, Inc., its generic finished dosage form subsidiary, has reached agreement to purchase three ANDAs from a subsidiary of Endo International plc for the products Methimazole Tablets, Glycopyrrolate Tablets and Meclizine Tablets.

Methimazole, the generic version of Pfizer's Tapazole, is indicated for the treatment of hyperthyroidism. Glycopyrrolate, the generic version of Shionogi's Robinul and Robinul Forte, are indicated for the treatment of peptic ulcers. Meclizine, the generic version of Citron's Antivert, is indicated for the treatment or prevention of nausea, vomiting and dizziness caused by motion sickness.